Programmed Death-Ligand 1 (PD-L1) is a protein that plays a critical role in the immune system’s ability to recognize and attack cancer cells. It binds to the PD-1 receptor on T-cells, effectively turning off the immune response to prevent autoimmunity. However, many cancers, including lung cancer, exploit this mechanism to evade immune detection.
